SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001894562-24-000003
Filing Date
2024-01-19
Accepted
2024-01-19 16:17:03
Documents
2
Period of Report
2024-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1705699014.html 3  
1 FORM 3 wk-form3_1705699014.xml 3 1677
2 EX-24 poa.txt EX-24 4428
  Complete submission text file 0001894562-24-000003.txt   7530
Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET BOSTON MA 02109
Business Address
Reine Allan (Reporting) CIK: 0001714023 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41536 | Film No.: 24545800

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)